220 related articles for article (PubMed ID: 26485229)
1. Alternative regimens of magnesium sulfate for treatment of preeclampsia and eclampsia: a systematic review of non-randomized studies.
Pratt JJ; Niedle PS; Vogel JP; Oladapo OT; Bohren M; Tunçalp Ö; Gülmezoglu AM
Acta Obstet Gynecol Scand; 2016 Feb; 95(2):144-56. PubMed ID: 26485229
[TBL] [Abstract][Full Text] [Related]
2. [Magnesium sulfate in obstetrics: current data].
Azria E; Tsatsaris V; Goffinet F; Kayem G; Mignon A; Cabrol D
J Gynecol Obstet Biol Reprod (Paris); 2004 Oct; 33(6 Pt 1):510-7. PubMed ID: 15567967
[TBL] [Abstract][Full Text] [Related]
3. Situational analysis of facilitators and barriers to availability and utilization of magnesium sulfate for eclampsia and severe preeclampsia in the public health system in Brazil.
Lotufo FA; Parpinelli MA; Osis MJ; Surita FG; Costa ML; Cecatti JG
BMC Pregnancy Childbirth; 2016 Aug; 16(1):254. PubMed ID: 27577571
[TBL] [Abstract][Full Text] [Related]
4. Alternative magnesium sulphate regimens for women with pre-eclampsia and eclampsia.
Duley L; Matar HE; Almerie MQ; Hall DR
Cochrane Database Syst Rev; 2010 Aug; 2010(8):CD007388. PubMed ID: 20687086
[TBL] [Abstract][Full Text] [Related]
5. Magnesium sulphate for the management of preeclampsia and eclampsia in low and middle income countries: a systematic review of tested dosing regimens.
Gordon R; Magee LA; Payne B; Firoz T; Sawchuck D; Tu D; Vidler M; de Silva D; von Dadelszen P
J Obstet Gynaecol Can; 2014 Feb; 36(2):154-163. PubMed ID: 24518915
[TBL] [Abstract][Full Text] [Related]
6. Open-labelled randomised controlled trial of 12 hours versus 24 hours modified Pritchard regimen in the management of eclampsia and pre-eclampsia in Ghana (MOPEP Study): study protocol.
Beyuo T; Lawrence E; Langen ES; Oppong SA
BMJ Open; 2019 Oct; 9(10):e032799. PubMed ID: 31641005
[TBL] [Abstract][Full Text] [Related]
7. Magnesium sulfate therapy in preeclampsia and eclampsia.
Witlin AG; Sibai BM
Obstet Gynecol; 1998 Nov; 92(5):883-9. PubMed ID: 9794688
[TBL] [Abstract][Full Text] [Related]
8. Duration of postpartum magnesium sulfate for seizure prophylaxis in women with preeclampsia: a systematic review and meta-analysis.
Sullivan M; Cunningham K; Angras K; Mackeen AD
J Matern Fetal Neonatal Med; 2022 Dec; 35(25):7188-7193. PubMed ID: 34187284
[TBL] [Abstract][Full Text] [Related]
9. A case-control evaluation of treatment efficacy: the example of magnesium sulfate prophylaxis against eclampsia in patients with preeclampsia.
Abi-Said D; Annegers JF; Combs-Cantrell D; Suki R; Frankowski RF; Willmore LJ
J Clin Epidemiol; 1997 Apr; 50(4):419-23. PubMed ID: 9179100
[TBL] [Abstract][Full Text] [Related]
10. Should magnesium sulfate be administered to women with mild pre-eclampsia? A systematic review of published reports on eclampsia.
Berhan Y; Berhan A
J Obstet Gynaecol Res; 2015 Jun; 41(6):831-42. PubMed ID: 25833188
[TBL] [Abstract][Full Text] [Related]
11. Magnesium sulphate in the treatment of eclampsia and pre-eclampsia: an overview of the evidence from randomised trials.
Chien PF; Khan KS; Arnott N
Br J Obstet Gynaecol; 1996 Nov; 103(11):1085-91. PubMed ID: 8916993
[TBL] [Abstract][Full Text] [Related]
12. A systematic review of maternal and infant outcomes following magnesium sulfate for pre-eclampsia/eclampsia in real-world use.
McDonald SD; Lutsiv O; Dzaja N; Duley L
Int J Gynaecol Obstet; 2012 Aug; 118(2):90-6. PubMed ID: 22703834
[TBL] [Abstract][Full Text] [Related]
13. Clinical pharmacokinetic properties of magnesium sulphate in women with pre-eclampsia and eclampsia.
Okusanya BO; Oladapo OT; Long Q; Lumbiganon P; Carroli G; Qureshi Z; Duley L; Souza JP; Gülmezoglu AM
BJOG; 2016 Feb; 123(3):356-66. PubMed ID: 26599617
[TBL] [Abstract][Full Text] [Related]
14. Loading Dose only versus Standard Dose Magnesium Sulfate Seizure Prophylaxis in Severe Pre-eclamptic Women.
Rimal SP; Rijal P; Bhatt R; Thapa K
JNMA J Nepal Med Assoc; 2017; 56(208):388-94. PubMed ID: 29453467
[TBL] [Abstract][Full Text] [Related]
15. A novel 12-hour versus 24-hour magnesium sulfate regimen in the management of eclampsia and preeclampsia in Ghana (MOPEP Study): A randomized controlled trial.
Beyuo TK; Lawrence ER; Kobernik EK; Oppong SA
Int J Gynaecol Obstet; 2022 Nov; 159(2):495-504. PubMed ID: 35304745
[TBL] [Abstract][Full Text] [Related]
16. Factors affecting use of magnesium sulphate for pre-eclampsia or eclampsia: a qualitative evidence synthesis.
Eddy KE; Vogel JP; Zahroh RI; Bohren MA
BJOG; 2022 Feb; 129(3):379-391. PubMed ID: 34520111
[TBL] [Abstract][Full Text] [Related]
17. A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia.
Lucas MJ; Leveno KJ; Cunningham FG
N Engl J Med; 1995 Jul; 333(4):201-5. PubMed ID: 7791836
[TBL] [Abstract][Full Text] [Related]
18. Serum magnesium levels during magnesium sulfate infusion at 1 gram/hour versus 2 grams/hour as a maintenance dose to prevent eclampsia in women with severe preeclampsia: A randomized clinical trial.
Pascoal ACF; Katz L; Pinto MH; Santos CA; Braga LCO; Maia SB; Amorim MMR
Medicine (Baltimore); 2019 Aug; 98(32):e16779. PubMed ID: 31393402
[TBL] [Abstract][Full Text] [Related]
19. Cerebral hemodynamics in preeclampsia: cerebral perfusion and the rationale for an alternative to magnesium sulfate.
Belfort MA; Clark SL; Sibai B
Obstet Gynecol Surv; 2006 Oct; 61(10):655-65. PubMed ID: 16978425
[TBL] [Abstract][Full Text] [Related]
20. The use of magnesium sulfate for women with severe preeclampsia or eclampsia diagnosed during the postpartum period.
Vigil-De Gracia P; Ludmir J
J Matern Fetal Neonatal Med; 2015; 28(18):2207-9. PubMed ID: 25373431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
